Hemerion Therapeutics
Company Management

Hemerion Therapeutics

Biotechnology Research Lille, Nord, Fr 15 employees
Employees
15
Contacts
1
Emails
1

Hemerion Therapeutics Overview

Headquarters
Lille, Nord, Fr
Website
hemerion.com
Industry
Biotechnology Research
Employees
15
Founded
2020
Funding
2.8M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Hemerion Therapeutics

Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

Hemerion Therapeutics Contact Details

People in AeroLeads
3
With contact data
1
Email contacts
1
33.3% coverage

Hemerion Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Clément Dupont Co-founder & CTO at Hemerion
View
Marine Coubronne Office Manager at Hemerion Therapeutics
View
Maximilien Vermandel Co-founder and CEO at Hemerion
Email

Employees by Management Level

Executive 2 profiles
Individual contributor 2 profiles
Manager 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Hemerion Therapeutics Tech Stack

Engineering 1 profile

Compare Similar Companies to Hemerion Therapeutics